Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study.

Hamm CW, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Bergland J, Piot C, Roubille F, Schult I, Allocco DJ, Nef H.

EuroIntervention. 2019 Nov 19. pii: EIJ-D-19-00051. doi: 10.4244/EIJ-D-19-00051. [Epub ahead of print]

2.

Plant architecture and phytochemical composition of basil (Ocimum basilicum L.) under the influence of light from microwave plasma and high-pressure sodium lamps.

Dörr OS, Brezina S, Rauhut D, Mibus H.

J Photochem Photobiol B. 2019 Oct 31;202:111678. doi: 10.1016/j.jphotobiol.2019.111678. [Epub ahead of print]

PMID:
31734433
3.

Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA.

Lipps C, Northe P, Figueiredo R, Rohde M, Brahmer A, Krämer-Albers EM, Liebetrau C, Wiedenroth CB, Mayer E, Kriechbaum SD, Dörr O, Nef H, Hamm CW, Keller T, Troidl C.

Biomolecules. 2019 Oct 29;9(11). pii: E666. doi: 10.3390/biom9110666.

4.

Lower mortality in an all-comers aortic stenosis population treated with TAVI in comparison to SAVR.

Möllmann H, Husser O, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Tesche C, Hamm CW, Elsässer A, Achenbach S, Gaede L.

Clin Res Cardiol. 2019 Oct 1. doi: 10.1007/s00392-019-01548-1. [Epub ahead of print]

PMID:
31573055
5.

Fractional flow reserve and frequency of PCI in patients with coronary artery disease.

Dörr O, Liebetrau C, Weferling M, Hoffmann F, Forderer N, Keller T, Boeder N, Blachutzik F, Keranov S, Bauer P, Bauer T, Hamm CW, Nef H.

Herz. 2019 Sep 4. doi: 10.1007/s00059-019-04848-4. [Epub ahead of print]

PMID:
31485776
6.

Elite athletes as research model: vitamin D insufficiency associates with elevated central blood pressure in professional handball athletes.

Bauer P, Kraushaar L, Hölscher S, Tajmiri-Gondai S, Dörr O, Nef H, Hamm C, Most A.

Eur J Appl Physiol. 2019 Oct;119(10):2265-2274. doi: 10.1007/s00421-019-04210-w. Epub 2019 Aug 19.

PMID:
31428859
7.

Prognostic performance of the ESC SCORE and its German recalibrated versions in primary and secondary prevention.

Elsner LK, Jeinsen BV, Grün D, Wolter JS, Weferling M, Diouf K, Kriechbaum S, Troidl C, Dörr O, Nef H, Hamm CW, Liebetrau C, Keller T.

Eur J Prev Cardiol. 2019 Aug 18:2047487319868034. doi: 10.1177/2047487319868034. [Epub ahead of print] No abstract available.

PMID:
31423815
8.

Impact of Vascular Function on Maximum Power Output in Elite Handball Athletes.

Bauer P, Kraushaar L, Most A, Hölscher S, Tajmiri-Gondai S, Dörr O, Troidl C, Bauer T, Nef H, Hamm CW, Keller T.

Res Q Exerc Sport. 2019 Dec;90(4):600-608. doi: 10.1080/02701367.2019.1639602. Epub 2019 Aug 9.

PMID:
31397640
9.

Transvascular transcatheter aortic valve implantation in 2017.

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Gülker J, Elsässer A, Hamm CW, Achenbach S, Möllmann H.

Clin Res Cardiol. 2019 Jun 24. doi: 10.1007/s00392-019-01509-8. [Epub ahead of print]

PMID:
31236692
10.

Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration).

Kim WK, Schäfer U, Tchetche D, Nef H, Arnold M, Avanzas P, Rudolph T, Scholtz S, Barbanti M, Kempfert J, Mangieri A, Lauten A, Frerker C, Yoon SH, Holzamer A, Praz F, De Backer O, Toggweiler S, Blumenstein J, Purita P, Tarantini G, Thilo C, Wolf A, Husser O, Pellegrini C, Burgdorf C, Antolin RAH, Díaz VAJ, Liebetrau C, Schofer N, Möllmann H, Eggebrecht H, Sondergaard L, Walther T, Pilgrim T, Hilker M, Makkar R, Unbehaun A, Börgermann J, Moris C, Achenbach S, Dörr O, Brochado B, Conradi L, Hamm CW.

Eur Heart J. 2019 Oct 7;40(38):3156-3165. doi: 10.1093/eurheartj/ehz429.

PMID:
31230081
11.

Predictive value of preprocedural procalcitonin for short- and long-term mortality after transfemoral transcatheter aortic valve implantation.

Keranov S, Kim WK, Arsalan M, Renker M, Keller T, Bauer T, Dörr O, Nef HM, Gaede L, Möllmann H, Walther T, Hamm CW, Liebetrau C.

Heart Vessels. 2019 Dec;34(12):1993-2001. doi: 10.1007/s00380-019-01448-4. Epub 2019 Jun 7.

PMID:
31175405
12.

Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.

Boeder NF, Dörr O, Bauer T, Elsässer A, Möllmann H, Achenbach S, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2019 Jun;20(6):480-484. doi: 10.1016/j.carrev.2018.07.030. Epub 2018 Aug 2.

PMID:
30638889
13.

Anti-citrullinated protein antibodies are not associated with extent of disease or prognosis in patients with coronary artery disease.

Diouf K, Elsner L, Rohr M, Wolter JS, Dörr O, Hamm CW, Liebetrau C, Keller T.

Clin Chem Lab Med. 2019 Jun 26;57(7):e159-e161. doi: 10.1515/cclm-2018-1097. No abstract available.

PMID:
30412464
14.

Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Ortlieb RM, Boeder N, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Nov;41(11):1474-1479. doi: 10.1002/clc.23089. Epub 2018 Nov 16.

15.

High prevalence of vitamin D insufficiency in professional handball athletes.

Bauer P, Henni S, Dörr O, Bauer T, Hamm CW, Most A.

Phys Sportsmed. 2019 Feb;47(1):71-77. doi: 10.1080/00913847.2018.1520055. Epub 2018 Sep 20.

PMID:
30196746
16.

One-Year Outcomes after PCI Strategies in Cardiogenic Shock.

Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators.

N Engl J Med. 2018 Nov 1;379(18):1699-1710. doi: 10.1056/NEJMoa1808788. Epub 2018 Aug 25.

17.

Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Sommer T, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Sep;41(9):1164-1169. doi: 10.1002/clc.22996. Epub 2018 Aug 20.

18.

Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Tabert H, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.

19.

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension.

Lauder L, Ewen S, Tzafriri AR, Edelman ER, Lüscher TF, Blankenstijn PJ, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F; Renal artery anatomy in hypertensive patients study collaborators.

EuroIntervention. 2018 May 20;14(1):121-128. doi: 10.4244/EIJ-D-18-00112.

20.

A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study.

Nef H, Wiebe J, Boeder N, Dörr O, Bauer T, Hauptmann KE, Latib A, Colombo A, Fischer D, Rudolph T, Foin N, Richardt G, Hamm C.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1021-1027. doi: 10.1002/ccd.27550. Epub 2018 Mar 6.

PMID:
29508518

Supplemental Content

Loading ...
Support Center